10-K Filing

SWK Holdings Corp CIK: 1089907 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001552781-21-000167`
Period End Date	20201231
Filing Date	20210331
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	swkh-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 44 Cash Flow Statement 80 Stockholders Equity 17 Comprehensive Income 6

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.16M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.23M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.01M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Interest and accounts receivable, net	`AccountsReceivableNet`	$1.91M	USD	Point-in-time
Interest and accounts receivable, net	`AccountsReceivableNet`	$2.55M	USD	Point-in-time
Marketable investments	`MarketableSecurities`	$1.21M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Marketable investments	`MarketableSecurities`	$1.80M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$783.00K	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$542.00K	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$6.67M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	12.79M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$16.30M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	12.92M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	12.92M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	12.79M	shares	Point-in-time
Finance receivables, net	`NotesAndLoansReceivableNetCurrent`	$172.82M	USD	Point-in-time
Finance receivables, net	`NotesAndLoansReceivableNetCurrent`	$204.49M	USD	Point-in-time
Marketable investments	`AvailableForSaleSecuritiesDebtSecurities`	$241.00K	USD	Point-in-time
Marketable investments	`AvailableForSaleSecuritiesDebtSecurities`	$466.00K	USD	Point-in-time
Investment in TRT	`InvestmentInTRTAtFairValue`	-	USD	Point-in-time
Investment in TRT	`InvestmentInTRTAtFairValue`	$3.49M	USD	Point-in-time
Deferred tax asset, net	`DeferredIncomeTaxAssetsNet`	$25.78M	USD	Point-in-time
Deferred tax asset, net	`DeferredIncomeTaxAssetsNet`	$27.49M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$3.56M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$2.97M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$25.11M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$13.62M	USD	Point-in-time
Goodwill	`Goodwill`	$8.40M	USD	Point-in-time
Goodwill	`Goodwill`	$8.40M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$1.29M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$5.21M	USD	Point-in-time
Other assets	`PrepaidExpenseAndOtherAssets`	$640.00K	USD	Point-in-time
Other assets	`PrepaidExpenseAndOtherAssets`	$1.31M	USD	Point-in-time
Total assets	`Assets`	$273.90M	USD	Point-in-time
Total assets	`Assets`	$254.37M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.06M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.65M	USD	Point-in-time
Revolving credit facility	`LinesOfCreditCurrent`	-	USD	Point-in-time
Revolving credit facility	`LinesOfCreditCurrent`	$11.76M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.41M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.06M	USD	Point-in-time
Contingent consideration payable	`ContingentConsiderationPayable`	$14.50M	USD	Point-in-time
Contingent consideration payable	`ContingentConsiderationPayable`	$16.90M	USD	Point-in-time
Warrant liability	`WarrantsAndRightsOutstanding`	$76.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$203.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.08M	USD	Point-in-time
Total liabilities	`Liabilities`	$33.39M	USD	Point-in-time
Total liabilities	`Liabilities`	$17.84M	USD	Point-in-time
Preferred Stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,792,586 and 12,917,348 shares issued and outstanding at December 31, 2020 and 2019, respectively	`CommonStockValue`	$13.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,792,586 and 12,917,348 shares issued and outstanding at December 31, 2020 and 2019, respectively	`CommonStockValue`	$13.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.43B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.43B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.19B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.20B	USD	Point-in-time
Total SWK Holdings Corporation stockholders' equity	`StockholdersEquity`	$240.51M	USD	Point-in-time
Total SWK Holdings Corporation stockholders' equity	`StockholdersEquity`	$213.06M	USD	Point-in-time
Total SWK Holdings Corporation stockholders' equity	`StockholdersEquity`	$236.53M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$254.37M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$273.90M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$30.80M	USD	Annual
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$30.12M	USD	Annual
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$5.90M	USD	Annual
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$621.00K	USD	Annual
Other	`RevenueNotFromContractWithCustomerOther`	$9.00K	USD	Annual
Other	`RevenueNotFromContractWithCustomerOther`	$9.00K	USD	Annual
Revenues	`Revenues`	$36.71M	USD	Annual
Revenues	`Revenues`	$30.75M	USD	Annual
Provision for loan credit losses	`ProvisionForLoanAndLeaseLosses`	-	USD	Annual
Provision for loan credit losses	`ProvisionForLoanAndLeaseLosses`	$2.21M	USD	Annual
Impairment expense	`OperatingLeaseImpairmentLoss`	$163.00K	USD	Annual
Impairment expense	`OperatingLeaseImpairmentLoss`	-	USD	Annual
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$1.18M	USD	Annual
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$4.27M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$7.43M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$10.55M	USD	Annual
Depreciation and amortization expense	`DepreciationAndAmortization`	$4.95M	USD	Annual
Depreciation and amortization expense	`DepreciationAndAmortization`	$12.09M	USD	Annual
Interest expense	`InterestExpense`	$338.00K	USD	Annual
Interest expense	`InterestExpense`	$455.00K	USD	Annual
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	$4.40M	USD	Annual
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	-	USD	Annual
Total costs and expenses	`CostsAndExpenses`	$31.92M	USD	Annual
Total costs and expenses	`CostsAndExpenses`	$16.11M	USD	Annual
Unrealized net gain on derivatives	`UnrealizedGainLossOnDerivatives`	$-586.00K	USD	Annual
Unrealized net gain on derivatives	`UnrealizedGainLossOnDerivatives`	$362.00K	USD	Annual
Unrealized net loss on equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-591.00K	USD	Annual
Unrealized net loss on equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$1.64M	USD	Annual
Loss on write off of investments	`MarketableSecuritiesGainLoss`	$197.00K	USD	Annual
Loss on write off of investments	`MarketableSecuritiesGainLoss`	$53.00K	USD	Annual
Income (loss) before provision (benifit) for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$3.67M	USD	Annual
Income (loss) before provision (benifit) for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$16.84M	USD	Annual
Benefit for income taxes	`IncomeTaxExpenseBenefit`	$-1.54M	USD	Annual
Benefit for income taxes	`IncomeTaxExpenseBenefit`	$-6.99M	USD	Annual
Consolidated net income	`ProfitLoss`	$5.20M	USD	Annual
Consolidated net income	`ProfitLoss`	$23.83M	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.40	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.85	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.85	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.40	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.85M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.91M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.91M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.86M	shares	Annual

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Consolidated net income	`ProfitLoss`	$5.20M	USD	Annual
Consolidated net income	`ProfitLoss`	$23.83M	USD	Annual
Provision for loan credit losses	`ProvisionForLoanAndLeaseLosses`	-	USD	Annual
Provision for loan credit losses	`ProvisionForLoanAndLeaseLosses`	$2.21M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$188.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$188.00K	USD	Annual
Impairment expense	`OperatingLeaseImpairmentLoss`	$163.00K	USD	Annual
Impairment expense	`OperatingLeaseImpairmentLoss`	-	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-1.71M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-7.10M	USD	Annual
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$586.00K	USD	Annual
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$-362.00K	USD	Annual
Change in fair value of equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-591.00K	USD	Annual
Change in fair value of equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$1.64M	USD	Annual
Gain on sale of investments	`MarketableSecuritiesGainLoss`	$197.00K	USD	Annual
Gain on sale of investments	`MarketableSecuritiesGainLoss`	$53.00K	USD	Annual
Change in fair value of convertible note receivable	`UnrealizedGainOnConvertibleNoteReceivable`	$149.00K	USD	Annual
Change in fair value of convertible note receivable	`UnrealizedGainOnConvertibleNoteReceivable`	-	USD	Annual
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	$4.40M	USD	Annual
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	-	USD	Annual
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$349.00K	USD	Annual
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$1.98M	USD	Annual
Interest paid-in-kind	`PaidInKindInterest`	$1.29M	USD	Annual
Interest paid-in-kind	`PaidInKindInterest`	$2.15M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$530.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$728.00K	USD	Annual
Interest income in excess of cash collected	`InterestIncomeInExcessOfCashCollected`	-	USD	Annual
Interest income in excess of cash collected	`InterestIncomeInExcessOfCashCollected`	$-82.00K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$19.27M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.95M	USD	Annual
Interest receivable	`IncreaseDecreaseInInterestAndDividendsReceivable`	$643.00K	USD	Annual
Interest receivable	`IncreaseDecreaseInInterestAndDividendsReceivable`	$-214.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$205.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$959.00K	USD	Annual
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.73M	USD	Annual
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.53M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$18.54M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$19.27M	USD	Annual
Acquisition of business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Acquisition of business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$19.72M	USD	Annual
Cash received from settlement of warrants	`CashReceivedFromSettlementOfWarrants`	-	USD	Annual
Cash received from settlement of warrants	`CashReceivedFromSettlementOfWarrants`	$53.00K	USD	Annual
Proceeds from sale of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	Annual
Proceeds from sale of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$197.00K	USD	Annual
Investment in equity securities	`IncreaseDecreaseInTradingSecurities`	-	USD	Annual
Investment in equity securities	`IncreaseDecreaseInTradingSecurities`	$159.00K	USD	Annual
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$51.04M	USD	Annual
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$42.86M	USD	Annual
Repayment of finance receivables	`ProceedsRepaymentOfFinanceReceivables`	$11.75M	USD	Annual
Repayment of finance receivables	`ProceedsRepaymentOfFinanceReceivables`	$43.98M	USD	Annual
Corporate debt security principal payment	`MarketableInvestmentPrincipalPayment`	$62.00K	USD	Annual
Corporate debt security principal payment	`MarketableInvestmentPrincipalPayment`	$66.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.94M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$48.00K	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$237.00K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-35.17M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-26.72M	USD	Annual
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$883.00K	USD	Annual
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$2.01M	USD	Annual
Net proceeds and payments under credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$11.76M	USD	Annual
Net proceeds and payments under credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	-	USD	Annual
Payment of acquisition-related contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	-	USD	Annual
Payment of acquisition-related contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$2.00M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$7.75M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-883.00K	USD	Annual
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-9.07M	USD	Annual
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-8.15M	USD	Annual
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.16M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$20.23M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.01M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.16M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$20.23M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.01M	USD	Point-in-time
Warrants received in connection with finance receivables	`WarrantsReceivedInConjunctionWithPurchaseOfFinancialReceivables`	$79.00K	USD	Annual
Warrants received in connection with finance receivables	`WarrantsReceivedInConjunctionWithPurchaseOfFinancialReceivables`	$353.00K	USD	Annual
Fair value of common stock issued in lieu of employee cash bonuses	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	-	USD	Annual
Fair value of common stock issued in lieu of employee cash bonuses	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$60.00K	USD	Annual
Contingent consideration in connection with business combination	`ContingentConsiderationInConnectionWithBusinessCombination`	-	USD	Annual
Contingent consideration in connection with business combination	`ContingentConsiderationInConnectionWithBusinessCombination`	$14.50M	USD	Annual

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$240.51M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$213.06M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$236.53M	USD	Point-in-time
Stock-based compensation	`ShareBasedCompensation`	$530.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$728.00K	USD	Annual
Issuance of common stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	Annual
Issuance of common stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	Annual
Issuance of common stock in lieu of employee cash bonuses	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	-	USD	Annual
Issuance of common stock in lieu of employee cash bonuses	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$60.00K	USD	Annual
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$2.01M	USD	Annual
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$883.00K	USD	Annual
Cumulative effect of adoption of New Accounting Principles	`NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification1`	-	USD	Annual
Net income	`ProfitLoss`	$5.20M	USD	Annual
Net income	`ProfitLoss`	$23.83M	USD	Annual
Ending Balance	`StockholdersEquity`	$240.51M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$213.06M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$236.53M	USD	Point-in-time

Comprehensive Income 6 line items

Line Item	Tag	Value	Unit	Period
Consolidated net income	`ProfitLoss`	$5.20M	USD	Annual
Consolidated net income	`ProfitLoss`	$23.83M	USD	Annual
Other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	Annual
Other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$23.83M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$5.20M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.